Prevalence and molecular characterization of extended-spectrum-β- lactamase-producing Enterobacteriaceae in a pediatric patient population

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 9, 2012, Pages 4765-4770

  Chandramohan, Lakshmi ^a,b   Revell, Paula A ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE CTX M; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; NITROFURANTOIN; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CHILDHOOD DISEASE; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; MORGANELLA MORGANII; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; REAL TIME POLYMERASE CHAIN REACTION; SERRATIA MARCESCENS; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFOTAXIME; CEFTAZIDIME; CHILD; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; ISOENZYMES; MALE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; TERTIARY CARE CENTERS; TEXAS;

EID: 84865410335     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00666-12     Document Type: Article

References (41)

1. Abdel-Hady H, Hawas S, El-Daker M, El-Kady R. 2008. Extended-spectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. J. Perinatol. 28:685-690.
2. Blanco J, et al. 2011. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b: H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J. Antimicrob. Chemother. 66:2011-2021.
3. Blomberg B, et al. 2005. High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J. Clin. Microbiol. 43:745-749. (Pubitemid 40256029)
4. Bouallegue-Godet O, et al. 2005. Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extendedspectrum beta-lactamase in a neonatal unit in Sousse, Tunisia. J. Clin. Microbiol. 43:1037-1044. (Pubitemid 40364914)
5. Canton R, Coque TM. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
6. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
7. Clermont O, et al. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
8. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. CLSI M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Coque TM, et al. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200. (Pubitemid 351213667)
10. Demir S, Soysal A, Bakir M, Kaufmann ME, Yagci A. 2008. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study. J. Paediatr. Child Health 44:548-553.
11. Dhanji H, et al. 2010. Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum beta-lactamases. Int. J. Antimicrob. Agents 36:355-358.
12. Duman M, Abacioglu H, Karaman M, Duman N, Ozkan H. 2005. Beta-lactam antibiotic resistance in aerobic commensal fecal flora of newborns. Pediatr. Int. 47:267-273. (Pubitemid 40827501)
13. Grisaru-Soen G, et al. 2007. Nosocomial bloodstream infections in a pediatric intensive care unit: 3-year survey. Med. Sci. Monit. 13:CR251-CR257. (Pubitemid 46855569)
14. Hawkey PM. 2008. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin. Microbiol. Infect. 14(Suppl. 1):159-165. (Pubitemid 350269196)
15. Herzer PJ, Inouye S, Inouye M, Whittam TS. 1990. Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J. Bacteriol. 172:6175-6181. (Pubitemid 20372753)
16. Jakobsen L, Hammerum AM, Frimodt-Moller N. 2010. Detection of clonal group A Escherichia coli isolates from broiler chickens, broiler chicken meat, community-dwelling humans, and urinary tract infection (UTI) patients and their virulence in a mouse UTI model. Appl. Environ. Microbiol. 76:8281-8284.
17. Johnson JR, et al. 2010. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob. Agents Chemother. 54:546-550.
18. Johnson JR, et al. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739.
19. Lartigue MF, et al. 2007. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob. Agents Chemother. 51:2855-2860.
20. Lascols C, et al. 2012. Using nucleic acid microarrays to perform molecular epidemiology and detect novel beta-lactamases: a snapshot of extended-spectrum beta-lactamases throughout the world. J. Clin. Microbiol. 50:1632-1639.
21. Lewis JS, II, Herrera M, Wickes B, Patterson JE, Jorgensen JH. 2007. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 51:4015-4021. (Pubitemid 350057800)
22. Livermore DM, et al. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174. (Pubitemid 47072053)
23. McGettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH. 2009. Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania. J. Clin. Microbiol. 47:2970-2974.
24. Nicolas-Chanoine MH, et al. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
25. Pallecchi L, et al. 2007. Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob. Agents Chemother. 51:2720-2725. (Pubitemid 47206205)
26. Paterson DL, et al. 2004. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin. Infect. Dis. 39:31-37. (Pubitemid 38879546)
27. Peirano G, Costello M, Pitout JD. 2010. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int. J. Antimicrob. Agents 36:19-23.
28. Peirano G, et al. 2010. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamaseproducing Escherichia coli isolates from Canada. Antimicrob. Agents Chemother. 54:1327-1330.
29. Pitout JD. 2010. Infections with extended-spectrum beta-lactamase- producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:313-333.
30. Pitout JD, et al. 2009. Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15. J. Clin. Microbiol. 47:1212-1215.
31. Qin X, et al. 2008. Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience. Antimicrob. Agents Chemother. 52:3909-3914.
32. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
33. Shahid M, et al. 2011. bla(CTX-M), bla(TEM), and bla(SHV) in Enterobacteriaceae from north-Indian tertiary hospital: high occurrence of combination genes. Asian Pac. J. Trop. Med. 4:101-105.
34. Sidjabat HE, et al. 2009. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob. Agents Chemother. 53:4733-4739.
35. Song W, et al. 2009. CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea. J. Med. Microbiol. 58:261-266.
36. Sun Y, et al. 2010. High prevalence of bla(CTX-M) extended-spectrum beta-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin. Microbiol. Infect. 16:1475-1481.
37. Tartof SY, Solberg OD, Manges AR, Riley LW. 2005. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J. Clin. Microbiol. 43:5860-5864. (Pubitemid 43100629)
38. Tian GB, et al. 2012. Detection of clinically important beta-lactamases in commensal Escherichia coli of human and swine origin in western China. J. Med. Microbiol. 61:233-238.
39. Wu TL, et al. 2003. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units. J. Clin. Microbiol. 41:4836-4838.
40. Yan JJ, et al. 2006. Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob. Agents Chemother. 50:1861-1864.
41. Yu Y, et al. 2007. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. J. Infect. 54:53-57. (Pubitemid 44932943)